Amgen Tarlatamab approved in UK for small cell lung cancer in adults Ruchika Sharma3 Jan 2025 12:57 PM ISTAmgen Limited has received approval for tarlatamab (Imdyllytra) from the Medicines and Healthcare products Regulatory Agency (MHRA) for the...
Nivolumab plus chemotherapy improves survival in Stage III Non-Small-Cell Lung Cancer: NEJM Chumbeni30 Jun 2023 8:00 PM ISTSpain: A recent study published in The New England Journal of Medicine has revealed that combining Nivolumab and Chemotherapy treatment in patients...
Medical Bulletin 27/March/2023 Dr. Nandita Mohan27 March 2023 5:15 PM ISTHere are the top medical news for the day:Study shows Buprenorphine after nonfatal opioid overdose reduces risk of overdose deathReceiving...
Saving more lung tissue in lung cancer surgeries supported in new study Isra Zaman27 March 2023 9:15 AM ISTThe traditional treatment for early-stage non-small cell lung cancer is a lobectomy, where a surgeon eradicates cancerous tissue by removing an entire...
Serplulimab plus chemotherapy improves survival in Extensive-Stage Small Cell Lung Cancer: JAMA Dr. Shravani Dali6 Oct 2022 8:15 PM ISTIn patients with extensive-stage small cell lung cancer, serplulimab plus chemotherapy as the first-line treatment resulted in improved overall...
Quitting Smoking After Lung Cancer Diagnosis Worth Doing Dr. Nandita Mohan17 May 2022 6:37 PM ISTThe researchers of the study revealed that smokers who quit smoking at or around lung cancer diagnosis have a 29% improvement in their overall...
Rare Case of Metastatic Uterine Tumor Mimicking Uterine Sarcoma Originating from Small-Cell Lung Cancer Dr Nirali Kapoor11 Aug 2021 8:30 AM ISTMetastatic uterine tumors originating from extragenital cancers are rare, while even rarer are uterine metastases from lung cancer. Mariko Fujima...
AstraZeneca small cell lung cancer treatment Imfinzi gets nod in China Ruchika Sharma19 July 2021 2:15 PM ISTUK: Pharma major, AstraZeneca, announced that Imfinzi (durvalumab) has been approved in China for the 1st-line treatment of adult patients with...
FDA approves osimertinib for treatment of non-small cell lung cancer Hina Zahid20 Dec 2020 7:45 AM ISTThe U.S. Food and Drug Administration has approved Tagrisso (osimertinib) as the first adjuvant treatment for patients with non-small cell lung cancer...
